| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2003;34:695.)
© 2003 American Heart Association, Inc.
Original Contributions |
From the Center for Noninvasive Brain Perfusion Studies, Stroke Program, University of Texas, Houston Medical School, Houston.
Correspondence to Dr A. Alexandrov, Department of Neurology, UTHSC, 6431 Fannin, MSB 7.044, Houston, TX 77030. E-mail avalexandrov{at}att.net
Background and Purpose Early arterial recanalization can lead to dramatic recovery (DR) during intravenous tissue plasminogen activator (tPA) therapy. However, it remains unclear whether this clinical recovery is sustained 3 months after stroke.
Methods We studied consecutive patients treated with intravenous tPA (0.9 mg/kg within 3 hours) who had M1 or proximal M2 middle cerebral artery occlusion on pretreatment transcranial Doppler according to previously validated criteria. Patients were continuously monitored for 2 hours after tPA bolus to determine complete, partial, or no early recanalization with the Thrombolysis in Brain Ischemia (TIBI) flow grading system. A neurologist obtained the National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) scores independently of transcranial Doppler results. DR was defined as a total NIHSS score of 0 to 3 points, and early recovery (ER) was defined improvement by
10 points at 2 hours after tPA bolus. Good long-term outcome was defined as an NIHSS score of 0 to 2 or an mRS score of 0 to 1 at 3 months.
Results Fifty-four patients with proximal middle cerebral artery occlusion had a median prebolus NIHSS score of 16 (range, 6 to 28; 90% with
10 points). The tPA bolus was given at 130±32 minutes (median, 120 minutes; 57% treated within the first 2 hours). DR+ER was observed in 50% of patients with early complete recanalization (n=18), 17% with partial recanalization (n=18), and 0% with no early recanalization (n=18) (P=0.025). Overall, DR+ER was observed in 12 patients (22%), and 9 (75%) had good outcome at 3 months in terms of NIHSS (P=0.009) and mRS (P=0.006) scores compared with non-DR and non-ER patients. If early recanalization was complete, 50% of these patients had good outcome at 3 months, and 78% with DR+ER sustained early clinical benefit. If recanalization was partial, 44% had good long-term outcome, and 66% of patients with DR+ER sustained the benefit. If no early recanalization occurred, 22% had good long-term outcome despite the lack of DR within 2 hours of tPA bolus (P=0.046). Mortality was 11%, 11%, and 39% in patients with complete, partial, and no early recanalization, respectively (P=0.025). Reasons for not sustaining DR in patients with early recanalization were subsequent symptomatic intracranial hemorrhage and recurrent ischemic stroke.
Conclusions DR or ER after recanalization within 2 hours after tPA bolus was sustained at 3 months in most patients (75%) in our study. Complete or partial early recanalization leads to better outcome at 3 months after stroke. Fewer patients achieve good long-term outcome without early recanalization.
Key Words: recovery of function stroke thrombolysis ultrasonography, Doppler, transcranial
This article has been cited by other articles:
![]() |
S. Sugiura, K. Iwaisako, S. Toyota, and H. Takimoto Simultaneous Treatment with Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset AJNR Am. J. Neuroradiol., June 1, 2008; 29(6): 1061 - 1066. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Janjua, A. Alkawi, M.F.K. Suri, and A.I. Qureshi Impact of Arterial Reocclusion and Distal Fragmentation during Thrombolysis among Patients with Acute Ischemic Stroke AJNR Am. J. Neuroradiol., February 1, 2008; 29(2): 253 - 258. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Uchino and D. C. Anderson Better late than never?: The story of arterial recanalization in acute ischemic stroke Neurology, April 24, 2007; 68(17): 1335 - 1336. [Full Text] [PDF] |
||||
![]() |
M. T. Wunderlich, M. Goertler, T. Postert, E. Schmitt, G. Seidel, G. Gahn, C. Samii, E. Stolz, and For the Duplex Sonography in Acute Stroke (DIAS) S Recanalization after intravenous thrombolysis: Does a recanalization time window exist? Neurology, April 24, 2007; 68(17): 1364 - 1368. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Tsivgoulis, M. Saqqur, V. K. Sharma, A. Y. Lao, M. D. Hill, A. V. Alexandrov, and for the CLOTBUST Investigators Association of Pretreatment Blood Pressure With Tissue Plasminogen Activator-Induced Arterial Recanalization in Acute Ischemic Stroke Stroke, March 1, 2007; 38(3): 961 - 966. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Saqqur, K. Uchino, A. M. Demchuk, C. A. Molina, Z. Garami, S. Calleja, N. Akhtar, F. O. Orouk, A. Salam, A. Shuaib, et al. Site of Arterial Occlusion Identified by Transcranial Doppler Predicts the Response to Intravenous Thrombolysis for Stroke Stroke, March 1, 2007; 38(3): 948 - 954. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Zangerle, S. Kiechl, M. Spiegel, M. Furtner, M. Knoflach, P. Werner, A. Mair, G. Wille, C. Schmidauer, K. Gautsch, et al. Recanalization after thrombolysis in stroke patients: Predictors and prognostic implications Neurology, January 2, 2007; 68(1): 39 - 44. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Shaltoni, K. C. Albright, N. R. Gonzales, R. U. Weir, A. M. Khaja, R. M. Sugg, M. S. Campbell III, E. D. Cacayorin, J. C. Grotta, and E. A. Noser Is Intra-Arterial Thrombolysis Safe After Full-Dose Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke? Stroke, January 1, 2007; 38(1): 80 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nedeltchev, U. Fischer, M. Arnold, P. Ballinari, T. Haefeli, L. Kappeler, C. Brekenfeld, L. Remonda, G. Schroth, and H. P. Mattle Long-Term Effect of Intra-Arterial Thrombolysis in Stroke Stroke, December 1, 2006; 37(12): 3002 - 3007. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Sugg, J. K. Pary, K. Uchino, S. Baraniuk, H. M. Shaltoni, N. R. Gonzales, R. Mikulik, Z. Garami, S. G. Shaw, D. E. Matherne, et al. Argatroban tPA Stroke Study: Study Design and Results in the First Treated Cohort. Arch Neurol, August 1, 2006; 63(8): 1057 - 1062. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamaguchi, E. Mori, K. Minematsu, J. Nakagawara, K. Hashi, I. Saito, Y. Shinohara, and for the Japan Alteplase Clinical Trial (J-ACT) Gro Alteplase at 0.6 mg/kg for Acute Ischemic Stroke Within 3 Hours of Onset: Japan Alteplase Clinical Trial (J-ACT) * Supplemental Appendix 2 Stroke, July 1, 2006; 37(7): 1810 - 1815. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sekoranja, J. Loulidi, H. Yilmaz, K. Lovblad, P. Temperli, M. Comelli, and R. F. Sztajzel Intravenous Versus Combined (Intravenous and Intra-Arterial) Thrombolysis in Acute Ischemic Stroke: A Transcranial Color-Coded Duplex Sonography-Guided Pilot Study Stroke, July 1, 2006; 37(7): 1805 - 1809. [Abstract] [Full Text] [PDF] |
||||
![]() |
R.M. Sugg, E.A. Noser, H.M. Shaltoni, N.R. Gonzales, M.S. Campbell, R. Weir, E.D. Cacayorin, and J.C. Grotta Intra-arterial reteplase compared to urokinase for thrombolytic recanalization in acute ischemic stroke. AJNR Am. J. Neuroradiol., April 1, 2006; 27(4): 769 - 773. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Marti-Fabregas, M. Borrell, D. Cocho, R. Belvis, M. Castellanos, J. Montaner, J. Pagonabarraga, A. Aleu, L. Molina-Porcel, J. Diaz-Manera, et al. Hemostatic markers of recanalization in patients with ischemic stroke treated with rt-PA Neurology, August 9, 2005; 65(3): 366 - 370. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. O. Zaidat, J. I. Suarez, J. L. Sunshine, R. W. Tarr, M. J. Alexander, T. P. Smith, D. S. Enterline, W. R. Selman, and D. M. D. Landis Thrombolytic Therapy of Acute Ischemic Stroke: Correlation of Angiographic Recanalization with Clinical Outcome AJNR Am. J. Neuroradiol., April 1, 2005; 26(4): 880 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Kim, Z. Garami, R. Mikulik, C. A. Molina, A. V. Alexandrov, and for the CLOTBUST Collaborators Early Recanalization Rates and Clinical Outcomes in Patients With Tandem Internal Carotid Artery/Middle Cerebral Artery Occlusion and Isolated Middle Cerebral Artery Occlusion Stroke, April 1, 2005; 36(4): 869 - 871. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Noser, H. M. Shaltoni, C. E. Hall, A. V. Alexandrov, Z. Garami, E. D. Cacayorin, J. K. Song, J. C. Grotta, and M. S. Campbell III Aggressive Mechanical Clot Disruption: A Safe Adjunct to Thrombolytic Therapy in Acute Stroke? Stroke, February 1, 2005; 36(2): 292 - 296. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Saposnik, B. Young, B. Silver, S. Di Legge, F. Webster, V. Beletsky, V. Jain, Y. Nilanont, and V. Hachinski Lack of Improvement in Patients With Acute Stroke After Treatment With Thrombolytic Therapy: Predictors and Association With Outcome JAMA, October 20, 2004; 292(15): 1839 - 1844. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Georgiadis, J. Oehler, S. Schwarz, V. Rousson, M. Hartmann, and S. Schwab Does acute occlusion of the carotid T invariably have a poor outcome? Neurology, July 13, 2004; 63(1): 22 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Seidel, K. Meyer-Wiethe, G. Berdien, D. Hollstein, D. Toth, and T. Aach Ultrasound Perfusion Imaging in Acute Middle Cerebral Artery Infarction Predicts Outcome Stroke, May 1, 2004; 35(5): 1107 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Molina, J. Montaner, J. F. Arenillas, M. Ribo, M. Rubiera, and J. Alvarez-Sabin Differential Pattern of Tissue Plasminogen Activator-Induced Proximal Middle Cerebral Artery Recanalization Among Stroke Subtypes Stroke, February 1, 2004; 35(2): 486 - 490. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Brown, K. C. Johnston, D. P. Wagner, and E. C. Haley Jr Predicting Major Neurological Improvement With Intravenous Recombinant Tissue Plasminogen Activator Treatment of Stroke Stroke, January 1, 2004; 35(1): 147 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. A. Molina, A. V. Alexandrov, A. M. Demchuk, M. Saqqur, K. Uchino, and J. Alvarez-Sabin Improving the Predictive Accuracy of Recanalization on Stroke Outcome in Patients Treated With Tissue Plasminogen Activator Stroke, January 1, 2004; 35(1): 151 - 156. [Abstract] [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |